Department of Hematology, The Affiliated Yantai Yuhuangding Hospital of Qingdao University, Yantai, Shandong, China.
Front Immunol. 2024 Sep 20;15:1450576. doi: 10.3389/fimmu.2024.1450576. eCollection 2024.
Our case demonstrated unique cytomegalovirus (CMV) encephalitis post-haploidentical donor hematopoietic stem cell transplantation (HID-HSCT), with early findings on diffusion-weighted brain magnetic resonance imaging (MRI) in the absence of any neurologic symptoms. A 54-year-old Chinese man with acute lymphoblastic leukemia (Philadelphia chromosome-negative) underwent HID-HSCT. After HSCT, the patient developed CMV viremia and severe acute graft-versus-host disease. Recurrence of CMV viremia was observed. On day 129, brain MRI was performed to determine the cause for the intermittent fever. Diffusion-weighted imaging (DWI) revealed several bright spots in the cortex of the frontal lobes and anterior angle of the left lateral ventricle. Subsequently, he developed transplant-associated thrombotic microangiopathy, posterior reversible encephalopathy syndrome, and enlargement of lesions alongside the ventricular wall on a brain MRI series. Metagenomic next-generation sequencing (NGS) of the cerebrospinal fluid (CSF) led to the final diagnosis of CMV encephalitis. Although ganciclovir combined with foscarnet was administered, the patient's consciousness deteriorated, followed by respiratory failure. The patient died on day 198. Additionally, we performed a systematic review to comprehensively analyze this disease. Regarding treatment, immunological therapies, including virus-specific T cells from a third donor and CMV-cytotoxic T lymphocytes, may be more effective. This case report and systematic review underscores the complexities of managing CMV ventriculoencephalitis in HSCT recipients and emphasizes the importance of early diagnosis by brain MRI and CSF polymerase chain reaction or NGS and ongoing research in improving outcomes.
我们的病例展示了独特的巨细胞病毒(CMV)脑炎在单倍体相合供者造血干细胞移植(HID-HSCT)后发生,且在无任何神经症状的情况下,弥散加权脑磁共振成像(MRI)上早期出现发现。一名 54 岁的中国男性,患有急性淋巴细胞白血病(费城染色体阴性),接受了 HID-HSCT。HSCT 后,患者出现 CMV 病毒血症和严重的急性移植物抗宿主病。观察到 CMV 病毒血症复发。在第 129 天,进行脑部 MRI 以确定间歇性发热的原因。弥散加权成像(DWI)显示额叶皮质和左外侧脑室前角有几个亮点。随后,他出现了移植相关血栓性微血管病、后部可逆性脑病综合征以及脑室壁旁病变的扩大。对脑脊液(CSF)进行宏基因组下一代测序(NGS)最终诊断为 CMV 脑炎。尽管给予更昔洛韦联合膦甲酸钠,但患者的意识恶化,随后出现呼吸衰竭。患者于第 198 天死亡。此外,我们进行了系统评价,以全面分析这种疾病。关于治疗,免疫疗法,包括来自第三位供者的病毒特异性 T 细胞和 CMV 细胞毒性 T 淋巴细胞,可能更有效。这个病例报告和系统评价强调了在 HSCT 受者中管理 CMV 脑室脑炎的复杂性,并强调了通过脑 MRI 和 CSF 聚合酶链反应或 NGS 早期诊断以及不断研究以改善结果的重要性。